US2009018312A1PendingUtilityA1

Igf-1 receptor interacting proteins

62
Assignee: LIGENSA TANJAPriority: Dec 3, 1998Filed: Sep 13, 2007Published: Jan 15, 2009
Est. expiryDec 3, 2018(expired)· nominal 20-yr term from priority
Inventors:Tanja LigensaRalf SchumacherMichael Weidner
A61P 35/00C07K 14/4702A61K 38/1709
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.

Claims

exact text as granted — not AI-modified
1 . An isolated recombinant polypeptide, wherein the isolated recombinant polypeptide (a) comprises an amino acid sequence that is a variant of SEQ ID NO:6 that is at least 90% identical to SEQ ID NO:6 and (b) binds to a human IGF-1 receptor.

Join the waitlist — get patent alerts

Track US2009018312A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.